Faculty of Medicine,Vajira Hospital
Bangkok, 10300, Thailand
NCT Number: NCT04940260
Preeclampsia (PE) is an important complication of pregnancy and can lead to chronic kidney disease by causing endothelial damage and podocyte loss, Soluble forms-like tyrosine kinase-1 (sFlt-1), placental growth factor (PlGF), sFlt1 / PlGF ratio and endoglin are the biomarkers for the differential diagnosis of preeclampsia and other diseases. We aim to explore the correlation of these biomarkers with long term renal function, blood pressure and urine albumin creatinine ratio (UACR) in PE patients.
Looking for future studies?
Notify Me18 year–40 year
All sexes
Observational
Bangkok, 10300, Thailand
This is prospective observational study.Study subjects are pregnant women aged more than 18 years more than 24 weeks of gestation who were diagnosed and classified as preeclampsia or gestational hypertension by the criteria recommends by the American College of Obstetricians and Gynecologists (ACOG).14
Severe preeclampsia will be diagnosed by:
Data collection and Laboratory Measurements Baseline demographic and clinical data will be recorded as follows: age, gestational age, blood pressure, medication history, parity. Laboratory data included complete blood count, blood urea nitrogen (BUN), creatinine, aspartate aminotransferase (AST), alanine aminotransferase (ALT), albumin, alkaline phosphate, lactate dehydrogenase (LDH), 24 -hour urine protein excretion and random urine protein-creatinine ratio. Enzyme-linked immunosorbent assay (ELISAs) for human soluble endoglin, SFlt1, and free PIGF will be conducted in duplicate with the use of commercial kits (R§D Systems).
The ratio of SFlt1:PIGF will be calculated. All the participants will be followed up at 3 months and 1 year in which blood pressure, UACR and serum creatinine will be recorded at each visit.
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Severe preeclampsia will be diagnosed by:
Exclusion criteria
chronic hypertension before pregnancy ,chronic kidney disease according to KDIGO criteria ,twin pregnancies,underlying diabetes mellitus
-
measure eGFR at one year post partum
measure urine protein creatinine ratio at one year postpartum
Time frame: 1 year
measure serum sFlt-1/PIGF and eGFR
Time frame: 1 year
measure serum sFlt-1/PIGF and blood pressure
Time frame: 1 year
measure serum sFlt-1/PIGF and UACR
Time frame: 1 year
measure endoglin and eGFR
Time frame: 1 year
measure endoglin and blood pressure
Time frame: 1 year
measure endoglin and UPCR
Bangkok Metropolitan Administration Medical College and Vajira Hospital
Other Gov
Long Term Renal Outcome in Preeclampsia : Role of sFlt-1 / PlGF and Endoglin
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05802940
Aspirin, Behavior
Danville, Pennsylvania, United States
View Trial DetailsNCT07717931
Cardiovascular Diseases, Female Urogenital Diseases and Pregnancy Complications
Multan, Punjab Province, Pakistan
View Trial DetailsNCT07265336
Female Urogenital Diseases and Pregnancy Complications, Hypertension, Pregnancy-Induced
Panama City, Provincia de Panamá, Panama
View Trial DetailsNCT07040696
Acute Kidney Injury, Female Urogenital Diseases
Cairo, Giza Governorate, Egypt
View Trial Details